A PPI, or proton pump inhibitor, is a type of medication that reduces stomach acid production by shutting down the acid-producing pumps in the lining of your stomach. PPIs are the most effective drugs available for treating gastroesophageal reflux disease (GERD), healing damaged esophageal tissue in about 78% of patients compared to 50% with older acid-reducing medications like H2 blockers (famotidine, for example). They’re available both over the counter and by prescription, and a standard course for GERD typically lasts eight weeks.
How PPIs Reduce Stomach Acid
Your stomach produces acid through tiny molecular pumps embedded in the walls of specialized cells called parietal cells. These pumps push hydrogen ions (acid) into the stomach in exchange for potassium ions. PPIs are actually prodrugs, meaning they aren’t active when you swallow them. They travel to the parietal cells, where the acidic environment chemically activates them. Once activated, they bind permanently to the acid pumps and shut them down.
Because each pump is permanently disabled, your body has to build new pumps before acid production returns to normal. This is why PPIs suppress acid far more effectively than H2 blockers, which only temporarily block one of several signals that trigger acid release. At standard doses, PPIs heal erosive esophagitis in about 82% of patients within eight weeks, compared to 52% for standard-dose H2 blockers.
Available PPIs
Seven PPIs are currently available in the United States:
- Omeprazole (Prilosec): 20 mg standard dose, available OTC
- Esomeprazole (Nexium): 20 mg standard dose, available OTC
- Lansoprazole (Prevacid): 30 mg standard dose, available OTC
- Pantoprazole (Protonix): 40 mg standard dose, prescription only
- Rabeprazole (AcipHex): 20 mg standard dose, prescription only
- Dexlansoprazole (Dexilant): prescription only
- Esomeprazole strontium: prescription only
The over-the-counter versions are typically sold at the same standard dose as their prescription counterparts. Prescription PPIs become relevant when your doctor wants a higher dose, a specific formulation, or a PPI that isn’t available OTC. High-dose regimens, which usually mean doubling the standard dose or taking it twice daily, are reserved for severe inflammation or cases that don’t respond to standard treatment.
When and How to Take Them
Timing matters with PPIs in a way it doesn’t with most medications. Because PPIs can only disable acid pumps that are actively working, and pumps activate when you eat, you need the drug circulating in your bloodstream before your meal begins. The recommended window is 30 to 60 minutes before eating, ideally before breakfast.
Taking a PPI with food or after a meal reduces its effectiveness. Food slows stomach emptying, delays absorption of the drug, and the higher acidity after eating can break down the pill’s protective coating too early. If you’ve been taking your PPI at bedtime or with meals and it doesn’t seem to be working well, switching to 30 minutes before breakfast is the single most impactful change you can make.
What a Standard Course Looks Like
The American College of Gastroenterology recommends an initial eight-week trial of a PPI taken once daily before a meal for people with classic GERD symptoms (heartburn and regurgitation) who don’t have alarm symptoms like difficulty swallowing or unintended weight loss. Symptom relief and esophageal healing tend to peak within that 8 to 12 week window.
After eight weeks, the next steps depend on what’s happening in your esophagus. People with mild or no visible damage can often step down to a lower dose, switch to on-demand use (taking the PPI only when symptoms flare), or try an H2 blocker instead. People with more severe esophageal erosion, classified as grade C or D, generally need to stay on PPI therapy long-term to prevent the damage from returning.
Long-Term Risks Worth Knowing
PPIs are safe and well-tolerated for most people over short courses. The concerns arise with long-term use, meaning a year or more, because suppressing stomach acid for extended periods interferes with how your body absorbs certain nutrients.
Vitamin B12 is the best-studied example. Your stomach needs acid to separate B12 from the proteins it’s bound to in food. In one study comparing long-term PPI users to nonusers, 75% of PPI users were B12 deficient compared to 11% of nonusers. The risk becomes meaningful after about 12 months of continuous use. People using PPIs for less than a year showed essentially no increased risk of B12 deficiency, while those on them for a year or more had roughly 4.5 times the risk.
The FDA issued warnings in 2010 and 2011 about two additional concerns. The first was an increased risk of bone fractures in the hip, wrist, and spine, particularly among people taking high doses or using PPIs for over a year. The second was low magnesium levels, which can cause muscle cramps, irregular heartbeat, and seizures in severe cases. Long-term PPI use has also been linked to reduced absorption of calcium, iron, and vitamin C, as well as a higher rate of a gut infection caused by Clostridioides difficile bacteria.
These risks don’t mean long-term PPIs are dangerous for everyone. For people with severe GERD or significant esophageal damage, the benefits of continued treatment clearly outweigh the risks. But for people taking PPIs out of habit or for mild symptoms that could be managed other ways, it’s worth periodically reassessing whether you still need them.
Rebound Acid When Stopping
One of the trickier aspects of PPI therapy is what happens when you stop. Your body responds to the prolonged suppression of acid by producing more of a hormone called gastrin, which signals the stomach to ramp up acid production. While you’re on the PPI, those signals are blocked. But when you stop taking it, all that extra signaling hits a stomach that now has an expanded capacity to produce acid, and you can temporarily end up with more acid than you had before you started treatment.
This rebound effect was demonstrated in a Norwegian study where pentagastrin-stimulated acid output increased by 50% above pre-treatment levels 14 days after stopping a three-month PPI course. In healthy volunteers who took PPIs and then stopped, 40 to 50% developed new gastrointestinal symptoms that weren’t present before treatment, compared to those who stopped a placebo.
Rebound symptoms often mimic GERD itself, which can create a cycle where people restart the medication thinking their condition has worsened. If you’re planning to stop a PPI after weeks or months of use, tapering the dose gradually rather than stopping abruptly helps minimize rebound symptoms and makes it easier to tell whether your original GERD symptoms are truly returning or your stomach is just readjusting.